???pagination.result.count???
???pagination.result.page???
1
N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. , Costa BM., J Pharmacol Exp Ther. November 1, 2009; 331 (2): 618-26.
Deregulation of NMDA-receptor function and down-stream signaling in APP[V717I] transgenic mice. , Dewachter I., Neurobiol Aging. February 1, 2009; 30 (2): 241-56.
The effect of competitive antagonist chain length on NMDA receptor subunit selectivity. , Feng B., Neuropharmacology. March 1, 2005; 48 (3): 354-9.
Monoamines directly inhibit N-methyl-D-aspartate receptors expressed in Xenopus oocytes in a voltage-dependent manner. , Masuko T., Neurosci Lett. November 16, 2004; 371 (1): 30-3.
Extrasynaptic NR2B and NR2D subunits of NMDA receptors shape 'superslow' afterburst EPSC in rat hippocampus. , Lozovaya NA., J Physiol. July 15, 2004; 558 (Pt 2): 451-63.
Oxygen sensitivity of NMDA receptors: relationship to NR2 subunit composition and hypoxia tolerance of neonatal neurons. , Bickler PE., Neuroscience. January 1, 2003; 118 (1): 25-35.
The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. , Rammes G., Neuropharmacology. May 1, 2001; 40 (6): 749-60.
Spermine potentiation of recombinant N-methyl-D-aspartate receptors is affected by subunit composition. , Zhang L., Proc Natl Acad Sci U S A. November 8, 1994; 91 (23): 10883-7.